Pnc Financial Services Group, Inc. Insmed Inc Transaction History

Pnc Financial Services Group, Inc.

$190 Billion
Q1 2025

A detailed history of Pnc Financial Services Group, Inc. transactions in Insmed Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 10,643 shares of INSM stock, worth $1.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,643

Previous 8,887 19.76%

Holding current value

$1.08 Million

Previous $613,000 32.3%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$65.25 - $83.83 $114,579 - $147,205	1,756 Added 19.76%	10,643 $811,000
Q4 2024 Feb 07, 2025	BUY	$66.29 - $76.63 $88,629 - $102,454	1,337 Added 17.71%	8,887 $613,000
Q3 2024 Nov 08, 2024	BUY	$62.0 - $79.01 $138,570 - $176,587	2,235 Added 42.05%	7,550 $551,000
Q2 2024 Aug 09, 2024	SELL	$22.0 - $69.71 $23,870 - $75,635	-1,085 Reduced 16.95%	5,315 $356,000
Q1 2024 May 10, 2024	BUY	$25.72 - $29.94 $24,511 - $28,532	953 Added 17.5%	6,400 $173,000
Q4 2023 Feb 09, 2024	BUY	$23.42 - $31.74 $1,779 - $2,412	76 Added 1.42%	5,447 $168,000
Q3 2023 Nov 13, 2023	SELL	$19.86 - $26.93 $4,130 - $5,601	-208 Reduced 3.73%	5,371 $135,000
Q2 2023 Aug 11, 2023	BUY	$16.44 - $21.1 $9,929 - $12,744	604 Added 12.14%	5,579 $117,000
Q1 2023 May 15, 2023	BUY	$16.26 - $21.73 $1,544 - $2,064	95 Added 1.95%	4,975 $84,000
Q4 2022 Feb 10, 2023	BUY	$16.98 - $23.15 $79,143 - $107,902	4,661 Added 2128.31%	4,880 $97,000
Q3 2022 Nov 10, 2022	BUY	$20.88 - $28.21 $4,468 - $6,036	214 Added 4280.0%	219 $4,000
Q2 2022 Aug 12, 2022	SELL	$17.07 - $25.71 $13,229 - $19,925	-775 Reduced 99.36%	5 $0
Q1 2022 May 12, 2022	BUY	$20.42 - $28.13 $15,825 - $21,800	775 Added 15500.0%	780 $18,000
Q4 2021 Feb 11, 2022	SELL	$25.89 - $33.45 $5,488 - $7,091	-212 Reduced 97.7%	5 $0
Q3 2021 Nov 05, 2021	SELL	$22.46 - $29.47 $239,131 - $313,767	-10,647 Reduced 98.0%	217 $5,000
Q2 2021 Aug 06, 2021	SELL	$24.17 - $36.01 $42,563 - $63,413	-1,761 Reduced 13.95%	10,864 $309,000
Q1 2021 May 07, 2021	SELL	$32.28 - $44.3 $81,184 - $111,414	-2,515 Reduced 16.61%	12,625 $430,000
Q4 2020 Feb 12, 2021	SELL	$31.45 - $40.54 $80,512 - $103,782	-2,560 Reduced 14.46%	15,140 $504,000
Q3 2020 Nov 06, 2020	BUY	$26.0 - $34.5 $118,066 - $156,664	4,541 Added 34.51%	17,700 $568,000
Q2 2020 Aug 07, 2020	BUY	$14.11 - $29.42 $184,558 - $384,813	13,080 Added 16556.96%	13,159 $362,000
Q1 2020 May 08, 2020	BUY	$13.63 - $33.98 $1,076 - $2,684	79 New	79 $1,000
Q4 2019 Feb 07, 2020	SELL	$16.12 - $24.98 $5,464 - $8,468	-339 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$15.49 - $25.78 $5,251 - $8,739	339 New	339 $5,000

Others Institutions Holding INSM

# of Institutions

489

Shares Held

197M

Call Options Held

892K

Put Options Held

1.77M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $13.8B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Insmed Inc Transaction History